Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
G protein-coupled receptor 180 (GPR180) is a transmembrane protein originally annotated as a seven-transmembrane orphan GPCR, primarily expressed in vascular smooth muscle cells and subsequently identified in diverse tissues including adipose and ocular tissue. GPR180 plays important roles in vascular remodeling, brown/beige adipocyte activation, and glucose metabolism. Importantly, recent structural and functional data show that GPR180 is not a canonical GPCR, lacking the conserved motifs and G-protein signaling features; instead, it acts as a component of the TGFβ receptor complex, mediating SMAD3 phosphorylation and integrating the signaling of its ligand, such as collagen triple helix repeat containing 1 (CTHRC1). GPR180's expression and function are linked to diseases such as congenital microcoria, metabolic disorders, restenosis, and possibly cancer. Although it does not have known approved drugs or antagonists/agonists, its role in these pathways makes it a potential, but still exploratory, therapeutic and biomarker target.
For potential ligands such as CTHRC1: Modulation of TGFβ signaling and adipocyte activation. No drugs reported with established mechanisms of action targeting GPR180.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on G protein-coupled receptor 180 (GPR180).